Skip to main content

Following the Cheerio Trail


                                              



cereal dish on brown wooden surface


Crunch!

Didn't I just sweep this floor? What on earth am I stepping on?

When my son was a toddler, I could often find him by tracking the trail of circular cereal pieces the dog hadn't got to first.

Years later, we no longer have a dog but the trail still exists. In three short months my Cheerio eater will be off to life in a dorm room. I hope his room mate is understanding or maybe sympathetic to this situation. Even more, it is my wish that said son will begin picking up after himself. An equally slavish roomie might be therapeutic but an obsessive cleaner could further enable this behavior. Six of one/ half a dozen of the other. Whatever...it will no longer be my problem.

                              Image result for messy dorm rooms

For a brief second I entertained the idea of thoroughly remodeling my boy's rooms once he vacates it for a higher education, but the closer that gets the more I mourn his absence. I know I am not alone and it will come as no surprise that my brain is flooded with "just yesterday" memories of my precious little tow-headed baby boy. 

Graduation is only a couple of weeks away. It has not been the greatest school year for my senior and that makes this school loving Mom very sad. While he is experiencing an an urgent need to get out of there and move on with his life, I just want to apply the brakes and pound some sense of school spirit into him.

We can't relive our fond memories through the eyes of our children, though, and I refuse to be the multitude of parents before me who swear their children will regret not embracing these memory making moments. But, he will...you know it and I know it...

That's just part of growing up. We are as guilty as our youngsters.

Even though that cereal trail is moving to a new location, my son's journey will continue to leave an impression on those around him.

Rock on , son! The future is your garden.

The Lady with the Cane




Cheerios, America's cereal. 






































https://www.amazon.com/Have-Whats-Your-Super-Power/dp/1882658442/ref=sr_1_fkmrnull_1?keywords=i+have+ms.+what%27s+your+superpower&qid=1556457191&s=gateway&sr=8-1-fkmrnull

Comments

Popular posts from this blog

Alien feet?

Okay, so after my initial reunion with social media, I naively imagined today to be more productive. But, no...

For someone who doesn't spend much time perusing sites like Pinterest, my interest has suddenly piqued to the point that addiction be a possibility.

Hoping to find someone of like mind, I instead downloaded a slipper pattern I might knit for Christmas presents (oops, there goes the surprise). It looks fairly simple. Let me know if you give it a try.
https://www.pinterest.com/pin/538250592959842993/

And, then, I found this really neat yoga flow outlined for me.
Since yoga seems to be the go-to exercise for us Warriors, I decided to share. That way we do not have to invent our own personalized routine. You're welcome.




Then, I discovered an entire page of memes that put MS in perspective to the causal reader-reluctant  on-looker. And because  this figure is essentially in the child pose... well, you get the picture.

Of course, any information on foot drop always attracts my at…

MS and children

FDA Approves First Treatment for Pediatric MS On May 11, 2018, Novartis announced that Gilenya® (fingolimod) was approved by the United States Food and Drug Administration (FDA) for the treatment of children and adolescents, ages 10 through 17, with relapsing multiple sclerosis (MS). This is the first disease-modifying therapy (DMT) to be approved for this form of the disease in this age group. Known as “pediatric MS,” nearly all of those diagnosed have the relapsing form of the disease. Children also experience approximately two-to-three times as many relapses as an individual with adult-onset MS. A clinical trial comparing Gilenya to Avonex® (interferon beta-1a) in children and adolescents found that those treated with Gilenya saw an 82-percent reduction in their annualized relapse rate over a period of up to two years. Please see MSAA's online news article, "FDA Approves Gilenya® for Pediatric MS,"for more information. If links are disabled in this email, please copy a…

9/11 Where were you?

Other than in March do I post multiple times during the week, but during my morning perusal of other MS blogs, I came across this very timely blog post. It reminded me early in the morn the significance of this very day: 9/11.
Any major event of disaster prompts us to reflect on the basic question of "where were you?" There is no doubt that you know very well where you were when the planes hit the Towers.
 Standing behind my podium in room 310 at Miller Junior High School, I looked up from my testing manual to glare at the intruder who opened the classroom door. I was giving a test. My students didn't need any distractions.
That didn't stop the neighboring science teacher who came directly up to me and whispered in my ear "The Twin Towers have been attacked. Meet in Steve's office next period."
I struggled to keep an unbiased face and continue my teacherly responsibilities. Several of my students were related to first res-ponders, fire fighters, and Nationa…